Additionally, nobiletin has been discovered to impede cancer angiogenesis in mammary carcinoma showing estrogen receptor positivity by restraining the signaling mediated by Src, FAK, and STAT3 while fostering PXN gene expression [44]. This evidence concerns the gene STAT3 and breast carcinoma.